Eli Lilly & Co. (LLY) option IV near lower end of range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Eli Lilly (LLY) PT Raised to $1,000 at Truist Securities
June 24, 2024 4:42 PM EDTTruist Securities analyst Robyn Karnauskas raised the price target on Eli Lilly (NYSE: LLY) to $1,000.00 (from $892.00) while maintaining a Buy rating.
The analyst comments "We are adjusting our model estimates ahead of the quarter to reflect script growth and management commentary on the quarter.... More
